Log in
Enquire now
Innoforce Pharmaceuticals

Innoforce Pharmaceuticals

Innoforce Pharmaceuticals is a contract Manufacturing, Biologics, Cell Therapy, Plasmids founded in 2018 by Yuling (Elaine) Li.

OverviewStructured DataIssuesContributors

Contents

innoforcepharma.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Engineering
Engineering
Pharmaceutical industry
Pharmaceutical industry
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Manufacturing
Manufacturing
Healthcare
Healthcare
...
Location
China
China
‌
Xiaoshan District
Founder
Yuling (Elaine) Li
Yuling (Elaine) Li
Pitchbook URL
pitchbook.com/profiles...458346-34
Legal Name
Innoforce Pharmaceuticals Co., Ltd.
Number of Employees (Ranges)
51 – 200
Email Address
info@innoforcepharma.com
Investors
Yanchuang Capital
Yanchuang Capital
China Highrun Capital Limited
China Highrun Capital Limited
‌
S&G CAPITAL
‌
Euland Venture
CICC ALPHA
CICC ALPHA
Advantech Capital
Advantech Capital
TriWise Capital
TriWise Capital
South China Venture Capital
South China Venture Capital
Founded Date
2018
Country
China
China
Headquarters
‌
Xiaoshan District

Other attributes

Company Operating Status
Active
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Innoforce Pharmaceuticals

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.